11.04.2017 • News

Henrik Stenqvist Becomes Recipharm's New CFO

Recipharm has appointed Henrik Stenqvist as the company's new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the headquarters in Stockholm, Sweden and reports to CEO Thomas Eldered.

Henrik Stenqvist brings 24 years' finance and management experience to Recipharm. Prior to joining the Swedish pharma Contract Development and Manufacturing Organization (CDMO) he served as CFO of the Meda Group and held other leading finance positions in the pharmaceutical industry. He holds a degree in Finance and Business Administration from the University of Linkoeping, Sweden.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.